Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cidara Therapeutics

18.92
-2.6200-12.16%
Post-market: 18.920.00000.00%16:40 EDT
Volume:151.45K
Turnover:3.04M
Market Cap:207.24M
PE:-0.71
High:22.04
Open:21.39
Low:18.78
Close:21.54
Loading ...

Press Release: Cidara Therapeutics Announces $105 Million Private Placement

Dow Jones
·
21 Nov 2024

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

GlobeNewswire
·
19 Nov 2024

Cidara Therapeutics Price Target Maintained With a $24.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Cidara Therapeutics’ CD388: Promising Influenza Prevention Drives Buy Rating

TIPRANKS
·
11 Nov 2024

Cidara Therapeutics Inc reports results for the quarter - Earnings Summary

Reuters
·
09 Nov 2024

Guggenheim Starts Cidara Therapeutics With Buy Rating, $33 Price Target

MT Newswires Live
·
08 Nov 2024

Cidara Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $33

THOMSON REUTERS
·
08 Nov 2024

Cidara Therapeutics Initiated at Buy by Guggenheim

Dow Jones
·
08 Nov 2024

Positive Outlook for Cidara Therapeutics Amid Strategic Advancements and Financial Stability

TIPRANKS
·
08 Nov 2024

Cidara Therapeutics: Q3 Earnings Snapshot

Associated Press Finance
·
08 Nov 2024

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

GlobeNewswire
·
31 Oct 2024

Cidara Therapeutics Inc expected to post a loss of $4.25 a share - Earnings Preview

Reuters
·
29 Oct 2024

Cidara Therapeutics Price Target Maintained With a $24.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Oct 2024

Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024

GlobeNewswire
·
16 Oct 2024

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
05 Oct 2024